Pluristem Therapeutics
- Biological Products, Except Diagnostic Substances
- Haifa, Israel
Compensation history
Top executives at Pluristem Therapeutics received an average of $1M per person in annual compensation from 2008 to 2023.
By year
Executives
We found four executives who work or worked at Pluristem Therapeutics.
News
Pluristem Therapeutics CEO Yaky Yanay's 2023 pay jumps 111% to $2.7M
May 1, 2024
Pluristem Therapeutics CEO Yaky Yanay's 2022 pay falls 86% to $1.3M
February 27, 2023
Pluristem Therapeutics Chairman Zami Aberman's 2020 pay falls 54% to $501K
April 8, 2021
Pluristem Therapeutics Chairman Zami Aberman's 2019 pay jumps 85% to $1.1M
May 20, 2020
Pluristem Therapeutics CEO Zami Aberman's 2018 pay falls 83% to $593K
April 25, 2019
Pluristem Therapeutics CEO Zami Aberman's 2013 pay rises 11% to $1.7M
March 31, 2014
Pluristem Therapeutics CEO Zami Aberman's 2012 pay rises 14% to $1.5M
March 29, 2013
Pluristem Therapeutics CEO Zami Aberman's 2011 pay jumps 134% to $1.3M
March 22, 2012
Pluristem Therapeutics CEO Zami Aberman's 2010 pay slips 4% to $559K
April 15, 2011
Pluristem Therapeutics CEO Zami Aberman's 2009 pay falls 24% to $580K
November 23, 2009
About Pluristem Therapeutics
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Biological Products, Except Diagnostic Substances
- Matam Advanced Technology Park, Building No. 5, Haifa, Israel 3508409
- 972-74-710-7171
- June 30
- Former names
- PLURISTEM THERAPEUTICS INC
- PLURISTEM LIFE SYSTEMS INC
- AI SOFTWARE INC